http://qrxpharma.com/download/file/cp/QRxPharma_Investor_Deck_March_2014_Final_(14_March_2014).pdf
Page 9 demonstrates the safety advantages of moxduo over either morphine or oxycodone. These are findings from Study 022 which is what the AdCom will be discussing.
